| NCK1-AS1 promotes the proliferation, migration, invasion, and EMT of non-small cell lung cancer by regulating the miR-361-5p/ADAM10 axis. | NCK1-AS1 promotes the proliferation, migration, invasion, and EMT of non-small cell lung cancer by regulating the miR-361-5p/ADAM10 axis.
Wu B, Wang Z, Xu H, Chu X, Jiang Q. | 12/20/2023 |
| A review on the role of NCK1 Antisense RNA 1 (NCK1-AS1) in diverse disorders. | A review on the role of NCK1 Antisense RNA 1 (NCK1-AS1) in diverse disorders.
Taheri M, Askari A, Behzad Moghadam K, Hussen BM, Ghafouri-Fard S, Kiani A. | 05/30/2023 |
| Long non-coding RNA NCK1-AS1 functions as a ceRNA to regulate cell viability and invasion in esophageal squamous cell carcinoma via microRNA-133b/ENPEP axis. | Long non-coding RNA NCK1-AS1 functions as a ceRNA to regulate cell viability and invasion in esophageal squamous cell carcinoma via microRNA-133b/ENPEP axis.
He XY, Wang XQ, Xiao QL, Liu D, Xu QR, Liu S., Free PMC Article | 02/14/2023 |
| LncRNA NCK1-AS1-mediated regulatory functions in human diseases. | LncRNA NCK1-AS1-mediated regulatory functions in human diseases.
Wang Y, Pan J, Sun Z. | 01/28/2023 |
| LncRNA NCK1-AS1 Aggravates Hepatocellular Carcinoma by the miR-22-3p/YARS Axis to Activate PI3K/AKT Signaling. | LncRNA NCK1-AS1 Aggravates Hepatocellular Carcinoma by the miR-22-3p/YARS Axis to Activate PI3K/AKT Signaling.
Zhou W, Wang J, Zhang J, Wang Y, Jiang L, Guo T, Luo B, Xu Q, Huang Y. | 05/7/2022 |
| NCK1-AS1 promotes the progression of lung squamous cell carcinoma through transcriptionally upregulating NCK1 via interacting with MYC. | NCK1-AS1 promotes the progression of lung squamous cell carcinoma through transcriptionally upregulating NCK1 via interacting with MYC.
Zhou X, Bao W, Zhang D, Yang Y, Du X, Qiu G., Free PMC Article | 01/1/2022 |
| Upregulation of lncRNA NCK1-AS1 predicts poor prognosis and contributes to non-small cell lung cancer proliferation by regulating CDK1. | Upregulation of lncRNA NCK1-AS1 predicts poor prognosis and contributes to non-small cell lung cancer proliferation by regulating CDK1.
Zha LF, Zhang LD, Pan HM, Ma HD. | 09/18/2021 |
| LncRNA NCK1-AS1 promotes non-small cell lung cancer progression via regulating miR-512-5p/p21 axis. | LncRNA NCK1-AS1 promotes non-small cell lung cancer progression via regulating miR-512-5p/p21 axis.
Luo X, Zhou J, Quan L, Liang Y, Huang P, Chen F, Liu S. | 08/28/2021 |
| NCK1-AS1 Increases Drug Resistance of Glioma Cells to Temozolomide by Modulating miR-137/TRIM24. | NCK1-AS1 Increases Drug Resistance of Glioma Cells to Temozolomide by Modulating miR-137/TRIM24.
Chen M, Cheng Y, Yuan Z, Wang F, Yang L, Zhao H. | 11/28/2020 |
| NCK1-AS1 promotes NCK1 expression to facilitate tumorigenesis and chemo-resistance in ovarian cancer. | NCK1-AS1 promotes NCK1 expression to facilitate tumorigenesis and chemo-resistance in ovarian cancer.
Chang H, Li B, Zhang X, Meng X. | 08/15/2020 |
| NCK1-AS1 functioned as a molecular sponge for miR-6857, antagonizing its ability to repress CDK1/6 protein translation. Findings suggest that NCK1-AS1/miR-6857/CDK1 crosstalk serve as a critical effector in cervical cancer progression. | LncRNA NCK1-AS1 promotes proliferation and induces cell cycle progression by crosstalk NCK1-AS1/miR-6857/CDK1 pathway.
Li H, Jia Y, Cheng J, Liu G, Song F., Free PMC Article | 11/30/2019 |